Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
105 hedge funds and large institutions have $359M invested in Taro Pharmaceutical Industries Ltd. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 29 reducing their positions, and 18 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 29
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
1% more funds holding
Funds holding: 104 → 105 (+1)
19% less capital invested
Capital invested by funds: $444M → $359M (-$85.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$12.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.3M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$7.8M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.9M |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$2.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$16.6M |
| 2 |
FCH
Freestone Capital Holdings
Seattle,
Washington
|
-$10.3M |
| 3 |
First Manhattan
New York
|
-$3.81M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.52M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.63M |
TARO Hedge Fund Activity: Q2 2019 in Review
105 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2019, worth a combined $359M — down 19% from $444M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new TARO positions and 18 closed out — a net gain of 1 holder — while 38 added to existing stakes and 29 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $12.5M. The largest seller was AJO LP, cutting an estimated $16.6M.
- 105 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2019, up from 104 in Q1 2019.
- Funds reported $359M of Taro Pharmaceutical Industries Ltd. stock for Q2 2019, down 19% quarter-over-quarter.
- 19 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2019 and 18 closed out, a net change of +1 holder.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2019 was Renaissance Technologies, an estimated $12.5M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2019 was AJO LP, an estimated $16.6M sold.
Based on aggregated 13F filings for Q2 2019.